The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-((R)-3-(1-(1-((R)-1-(2,4-Dichlorophenyl)ethyl)-3-methyl-1H-pyrazolo[3,4-b]pyrazin-6-yl)azetidin-3-yl)piperidin-1-yl)ethyl)methanesulfonamide ID: ALA4647188
PubChem CID: 134210845
Max Phase: Preclinical
Molecular Formula: C25H33Cl2N7O2S
Molecular Weight: 566.56
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nn([C@H](C)c2ccc(Cl)cc2Cl)c2nc(N3CC([C@H]4CCCN(CCNS(C)(=O)=O)C4)C3)cnc12
Standard InChI: InChI=1S/C25H33Cl2N7O2S/c1-16-24-25(34(31-16)17(2)21-7-6-20(26)11-22(21)27)30-23(12-28-24)33-14-19(15-33)18-5-4-9-32(13-18)10-8-29-37(3,35)36/h6-7,11-12,17-19,29H,4-5,8-10,13-15H2,1-3H3/t17-,18+/m1/s1
Standard InChI Key: UBQUARZVFOTNKI-MSOLQXFVSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
13.8881 -14.4494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4837 -15.1593 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.3007 -15.1546 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7197 -15.4069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7185 -16.2264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4266 -16.6354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1363 -16.2260 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4248 -14.9980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1306 -15.4063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7371 -14.8613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4060 -14.1160 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5951 -14.2006 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0488 -13.5929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3019 -12.8159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2493 -13.7621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1019 -12.6482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3552 -11.8721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8086 -11.2634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0056 -11.4361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7560 -12.2120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9571 -12.3839 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
20.0608 -10.4861 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
21.5362 -15.0319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0105 -16.6345 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2230 -16.4236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0109 -17.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8001 -17.4249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3023 -17.6253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5951 -17.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8892 -17.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8843 -18.4361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5916 -18.8474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3037 -18.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1834 -17.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1871 -16.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4813 -15.9777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7792 -14.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 9 1 0
8 4 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
12 13 1 0
13 14 1 0
13 15 1 6
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
20 21 1 0
18 22 1 0
10 23 1 0
5 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 24 1 0
28 29 1 0
28 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
28 26 1 1
30 34 1 0
34 35 1 0
35 36 1 0
36 2 1 0
2 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 566.56Molecular Weight (Monoisotopic): 565.1793AlogP: 3.75#Rotatable Bonds: 8Polar Surface Area: 96.25Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.35CX Basic pKa: 8.24CX LogP: 2.86CX LogD: 1.96Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.44Np Likeness Score: -1.47
References 1. Robles O, Jackson JJ, Marshall L, Talay O, Chian D, Cutler G, Diokno R, Hu DX, Jacobson S, Karbarz E, Kassner PD, Ketcham JM, McKinnell J, Meleza C, Reilly MK, Riegler E, Shunatona HP, Wadsworth A, Younai A, Brockstedt DG, Wustrow DJ, Zibinsky M.. (2020) Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors., 63 (15): [PMID:32667798 ] [10.1021/acs.jmedchem.0c00988 ]